Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.4B |
| Enterprise Value | 2.2B |
| P/E Ratio | 13.6 |
| PEG Ratio | -0.45 |
| Price/Sales Ratio | 3.83 |
| Price/Book Ratio | 2.17 |
| Enterprise/Revenue | 3.78 |
| Enterprise/EBITDA | 11.57 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.21 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 812.35M |
| Revenue/Share | 1.86 |
| Gross Profit | 567.01M |
| EBITDA | 322.38M |
| Net Income | 195.12M |
| Diluted EPS | 0.61 |
Balance Sheet
| Total Cash | 256.42M |
| Total Cash/Share | 0.58 |
| Total Debt | 126.36M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 1.68 |
| Book Value Per Share | 3.21 |
Price History
| 52-Week Change | -30.83 |
| 52-Week High | 10.06 |
| 52-Week Low | 6.83 |
| Moving Average 50 Days | 7.33 |
| Moving Average 200 Days | 7.93 |
Statistics
| Average Volume | 6.15M |
| Shares Outstanding | 458.23M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.3 |
| Trailing Annual Dividend Yield | 4.34 |
| Payout Ratio | 0.56 |
| Last Split Factor | 7:5 |
| Last Split Date | June 26, 2026 |
AD
